Opendata, web and dolomites


Moving to Efficient Diabetes care: Multimode Integrated CO-morbidity diagnostics platform

Total Cost €


EC-Contrib. €






 MEDMICO project word cloud

Explore the words cloud of the MEDMICO project. It provides you a very rough idea of what is the project "MEDMICO" about.

breakthrough    epidemic    patient    pharmacies    combat    adult    population    multiple    sensitivity    ready    usability    ischemic    complications    biomaterials    quad    care    near    diagnostic    temperature    spearhead    mode    evidenced    hba1c    diabetes    primary    pilot    life    trinity    integrating    gt    incorporates    abnormalities    comorbidity    laboratories    extensive    incumbent    contractor    point    regulatory    dublin    storage    morbid    outcomes    poct    1st    precision    vitro    diagnose    projections       accuracy    validated    shift    clinical    tests    trl8    monitor    chemistry    workflow    efficient    prototype    cardiovascular    heart    innovation    creatinine    co    diabetic    efficiencies    2013    positioning    immunoassays    revenues    central    away    forefront    panels    outpatient    validation    optimal    diagnostics    majority    sub    12    cell    renal    2035    delivering    date    radisens    counting    lab    shelf    lipids    segments    platform    disruptive    pipette    provides    kidney    healthcare    clinics    drive    college    comorbid    months    room    launch       single    expertise    rising    disease    turbidimetry    comorbidities    medmico    submission    patients    trials    screen   

Project "MEDMICO" data sheet

The following table provides information about the project.


Organization address
city: CORK
postcode: IP31 HF29

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website
 Total cost 4˙487˙525 €
 EC max contribution 4˙487˙525 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2014
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2018-12-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RADISENS DIAGNOSTICS LIMITED IE (CORK) coordinator 4˙487˙525.00


 Project objective

Diabetes affects 8.5% (2013) of the adult European population rising to 10.3% (2035) and is associated with co-morbid conditions such as cardiovascular and renal abnormalities. These lead to diabetic complications, ischemic heart disease, heart failure and kidney failure. Management of this growing epidemic requires a shift in care management and delivery, away from lab testing. The majority of current diagnostic testing for diabetes and comorbidities involves central laboratories as incumbent in-vitro diagnostic point-of-care testing (PoCT) provides sub-optimal accuracy and single tests (rather than needed panels) for diabetes and its comorbidities. MEDMICO will spearhead a diagnostic breakthrough by delivering the 1st quad-mode PoCT platform integrating immunoassays, turbidimetry, clinical chemistry and cell counting. HbA1c, Lipids and Creatinine tests will be integrated on to a single diabetes comorbid platform with state-of-the-art sensitivity/precision, room temperature storage, >12 months’ shelf-life and integrated pipette to screen, diagnose and monitor patients, within primary care, outpatient clinics and pharmacies. This will improve patient outcomes and healthcare efficiencies, positioning Europe at the forefront of healthcare innovation and deliver an efficient platform to combat this epidemic. MEDMICO incorporates extensive technical, clinical and exploitation expertise - Radisens’ disruptive PoCT prototype and Trinity College Dublin (sub-contractor) biomaterials expertise and diabetes patient access. MEDMICO’s potential is evidenced by Radisens’ revenues to date and large near-term projections from diagnostics partners before its launch. Existing research of end-user needs and workflow assessment will drive platform development and pilot production, with clinical validation and usability trials in multiple PoCT segments to TRL8. This will deliver a validated quad-mode diabetes comorbidity platform, ready for regulatory submission.


List of deliverables.
Target stakeholder web site & project presentation Websites, patent fillings, videos etc. 2019-07-24 15:31:59

Take a look to the deliverables list in detail:  detailed list of MEDMICO deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDMICO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDMICO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  


Integrating and decentralising diabetes and hypertension services in Africa

Read More  


ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More